DSM-Firmenich AG (AMS:DSFIR)
Netherlands
· Delayed Price · Currency is EUR 64.30
+0.74 (1.16%)
Apr 29, 2026, 12:34 PM CET
DSM-Firmenich AG Revenue
In the year 2025, DSM-Firmenich AG had annual revenue of 9.03B EUR, down -0.22%.
Revenue
9.03B
Revenue Growth
-28.45%
P/S Ratio
1.76
Revenue / Employee
336.17K
Employees
26,873
Market Cap
15.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.03B | -20.00M | -0.22% |
| Dec 31, 2024 | 9.05B | -1.57B | -14.80% |
| Dec 31, 2023 | 10.63B | 2.24B | 26.66% |
| Dec 31, 2022 | 8.39B | 1.12B | 15.42% |
| Dec 31, 2021 | 7.27B | -837.00M | -10.33% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcelorMittal | 52.25B |
| Akzo Nobel | 9.93B |
| IMCD N.V. | 4.81B |
| Aperam | 6.08B |
| AMG Critical Materials | 1.45B |
| Corbion | 1.27B |
| OCI N.V. | 924.95M |
| Avantium | 14.59M |
DSM-Firmenich AG News
- 6 weeks ago - DSM-Firmenich AG Transcript: Investor update - Transcripts
- 6 weeks ago - dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation - GlobeNewsWire
- 6 weeks ago - dsm-firmenich announces share repurchase program to cover share plans and reduce capital - GlobeNewsWire
- 2 months ago - dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program - GlobeNewsWire
- 2 months ago - dsm-firmenich publishes 2025 Integrated Annual Report - GlobeNewsWire
- 2 months ago - dsm-firmenich issues €1.5 billion long-term bonds - GlobeNewsWire
- 2 months ago - DSM-Firmenich AG Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH) - GlobeNewsWire